These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8530151)

  • 61. Kinetics of cytokine and NFAT gene expression in human interleukin-2-dependent T lymphoblasts stimulated via T-cell receptor.
    Sareneva T; Matikainen S; Vanhatalo J; Melén K; Pelkonen J; Julkunen I
    Immunology; 1998 Mar; 93(3):350-7. PubMed ID: 9640245
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immunosuppressive effect of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through the inhibition of T-lymphocyte proliferation and IL-2 production.
    Yun CH; Son CG; Jung U; Han SH
    Toxicology; 2006 Jan; 217(1):31-8. PubMed ID: 16168555
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Induction of interleukin 2 messenger RNA inhibited by cyclosporin A.
    Elliott JF; Lin Y; Mizel SB; Bleackley RC; Harnish DG; Paetkau V
    Science; 1984 Dec; 226(4681):1439-41. PubMed ID: 6334364
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Calcineurin potentiates activation of the granulocyte-macrophage colony-stimulating factor gene in T cells: involvement of the conserved lymphokine element 0.
    Tsuboi A; Masuda ES; Naito Y; Tokumitsu H; Arai K; Arai N
    Mol Biol Cell; 1994 Jan; 5(1):119-28. PubMed ID: 8186461
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Overexpression of p65 and c-Jun substitutes for B7-1 costimulation by targeting the CD28RE within the IL-2 promoter.
    Parra E; McGuire K; Hedlund G; Dohlsten M
    J Immunol; 1998 Jun; 160(11):5374-81. PubMed ID: 9605137
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Posttranscriptional regulation of T-cell IL-2 production by human pooled immunoglobin.
    Modiano JF; Amran D; Lack G; Bradley K; Ball C; Domenico J; Gelfand EW
    Clin Immunol Immunopathol; 1997 Apr; 83(1):77-85. PubMed ID: 9073539
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Constitutive expression of interferon gamma-inducible protein 10 in lymphoid organs and inducible expression in T cells and thymocytes.
    Gattass CR; King LB; Luster AD; Ashwell JD
    J Exp Med; 1994 Apr; 179(4):1373-8. PubMed ID: 8145049
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Involvement of a common transcription factor in the regulated expression of IL-2 and IL-2 receptor genes.
    Shibuya H; Yoneyama M; Taniguchi T
    Int Immunol; 1989; 1(1):43-9. PubMed ID: 2518655
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Analysis of IL-2, IL-4, and IFN-gamma-producing cells in situ during immune responses to protein antigens.
    Bogen SA; Fogelman I; Abbas AK
    J Immunol; 1993 May; 150(10):4197-205. PubMed ID: 8482832
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immunology. A breath of Aire for the periphery.
    Kyewski B
    Science; 2008 Aug; 321(5890):776-7. PubMed ID: 18687943
    [No Abstract]   [Full Text] [Related]  

  • 71. Molecular mechanisms underlying differential contribution of CD28 versus non-CD28 costimulatory molecules to IL-2 promoter activation.
    Zhou XY; Yashiro-Ohtani Y; Nakahira M; Park WR; Abe R; Hamaoka T; Naramura M; Gu H; Fujiwara H
    J Immunol; 2002 Apr; 168(8):3847-54. PubMed ID: 11937538
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cannabinol enhancement of interleukin-2 (IL-2) expression by T cells is associated with an increase in IL-2 distal nuclear factor of activated T cell activity.
    Jan TR; Rao GK; Kaminski NE
    Mol Pharmacol; 2002 Feb; 61(2):446-54. PubMed ID: 11809870
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The transcriptional paradox: octamer factors and B and T cells.
    Graef IA; Crabtree GR
    Science; 1997 Jul; 277(5323):193-4. PubMed ID: 9235633
    [No Abstract]   [Full Text] [Related]  

  • 74. One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.
    Briegel K; Hentsch B; Pfeuffer I; Serfling E
    Nucleic Acids Res; 1991 Nov; 19(21):5929-36. PubMed ID: 1945879
    [TBL] [Abstract][Full Text] [Related]  

  • 75. IL-2-dependent expression of genes involved in cytoskeleton organization, oncogene regulation, and transcriptional control.
    Herblot S; Chastagner P; Samady L; Moreau JL; Demaison C; Froussard P; Liu X; Bonnet J; Thèze J
    J Immunol; 1999 Mar; 162(6):3280-8. PubMed ID: 10092780
    [TBL] [Abstract][Full Text] [Related]  

  • 76. GM-CSF promoter chromatin remodelling and gene transcription display distinct signal and transcription factor requirements.
    Brettingham-Moore KH; Rao S; Juelich T; Shannon MF; Holloway AF
    Nucleic Acids Res; 2005; 33(1):225-34. PubMed ID: 15647505
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The interplay between lymphoid-specific and ubiquitous transcription factors controls the expression of interleukin 2 gene in T lymphocytes.
    Avots A; Escher C; Müller-Deubert S; Neumann M; Serfling E
    Immunobiology; 1995 Jul; 193(2-4):254-8. PubMed ID: 8530151
    [No Abstract]   [Full Text] [Related]  

  • 78. The mechanism of tissue-restricted antigen gene expression by AIRE.
    Zumer K; Saksela K; Peterlin BM
    J Immunol; 2013 Mar; 190(6):2479-82. PubMed ID: 23456700
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The weak, fine-tuned binding of ubiquitous transcription factors to the Il-2 enhancer contributes to its T cell-restricted activity.
    Hentsch B; Mouzaki A; Pfeuffer I; Rungger D; Serfling E
    Nucleic Acids Res; 1992 Jun; 20(11):2657-65. PubMed ID: 1614851
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Reconstitution of T cell-specific transcription directed by composite NFAT/Oct elements.
    Bert AG; Burrows J; Hawwari A; Vadas MA; Cockerill PN
    J Immunol; 2000 Nov; 165(10):5646-55. PubMed ID: 11067921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.